Global Infectious Disease Diagnostics Market | Growth, Trends And Forecast TillPosted by Kavita on July 25th, 2019 Bharat Book Bureau Provides the Trending Market Research Report on “Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography – Global Forecast to 2025” under Diagnostics Category. The report provides information on industry overview, market size, latest developments, industry trends, Key Manufacturers, global presence,device to communicate and their future prospects. Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography–Global Forecast to 2025 The global infectious disease diagnostics market is expected to grow at a CAGR of 5.9% from 2018 to reach .4 billion by 2025. Request a Free Sample Copy of Infectious Disease Diagnostics Market Report @ On the basis of product type, the assays and kits segment dominated the global infectious disease diagnostics market in 2018, owing to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. On the basis of technology, immunodiagnostics accounted for the largest share of the global infectious disease diagnostics market. This is owing to the increasing use of immunoassays in POC infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments. Hepatitis segment held the largest share of the infectious disease diagnostics market. This is mainly attributed to the increasing prevalence of hepatitis B & C infection, rising susceptibility of the geriatric population, growing awareness among the population, and increasing availability of various molecular diagnostic technologies. Based on end user, the hospital/clinical laboratories segment held the major share in 2018. This is primarily attributed to the increasing number of outpatients for infectious diseases, increasing hospital expenditures, growing technological advancement for diagnostic platforms in hospitals, and increasing number of skilled professionals. An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global infectious disease diagnostics market in 2018, followed by Europe and Asia Pacific. The large share of this region is mainly attributed to the factors such as growing healthcare sector, increasing need to treat various infectious diseases, growing healthcare expenditure, increasing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population. The major players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.) among others. Scope of the Report: Infectious Disease Diagnostics Market, by Technology Infectious Disease Diagnostics Market, by Disease Type Infectious Disease Diagnostics Market, by End User Infectious Disease Diagnostics Market, by Region Browse our full report with Table of Contents : About Bharat Book Bureau: Contact us at: Like it? Share it!More by this author |